AMPROL Hi-E® and BMD®

Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States

  • Animal drug application 36304
  • Animal drug product ID 461

What the source publishes

Holder
Huvepharma EOOD
Active ingredients
Amprolium Bacitracin methylenedisalicylate Ethopabate
Form
Type A medicated articles
Routes
Oral
Supply regime
OTC

Names this record is found by

Complete source data
us:fda:animaldrugs:372:461
{
  "form": "Type A medicated articles",
  "name": "AMPROL Hi-E® and BMD®",
  "holder": "Huvepharma EOOD",
  "routes": [
    "Oral"
  ],
  "smpcUrl": null,
  "marketed": null,
  "useDomain": "veterinary",
  "leafletUrl": null,
  "supplyRegime": "OTC",
  "nativeProduct": {
    "routes": [
      "Oral"
    ],
    "species": {
      "Chickens:431": "Broilers up to 16 weeks",
      "Chickens:443": "Replacements, excluding laying hens"
    },
    "sortOrder": 0,
    "withdrawals": [],
    "doseFormName": "Type A medicated articles",
    "applicationId": null,
    "specifications": "Type A medicated articles: 25 percent amprolium and 8 percent ethopabate and 10, 25, 30, 40, 50, 60, or 75 grams bacitracin methylenedisalicylate per pound",
    "proprietaryName": "AMPROL Hi-E® and BMD®",
    "proprietaryNameId": 461,
    "statusDescription": "OTC"
  },
  "nativeSummary": {
    "noohDate": null,
    "publishDate": "2026-02-13",
    "sponsorName": "Huvepharma EOOD",
    "applicationId": 372,
    "applicationType": "N",
    "proprietaryName": "AMPROL Hi-E® and BMD®\n",
    "applicationNumber": 36304,
    "activeIngredientName": "Amprolium\nBacitracin methylenedisalicylate\nEthopabate\n",
    "applicationStatusCode": "A",
    "applicationStatusValue": null,
    "voluntaryWithdrawalDate": null
  },
  "targetSpecies": [
    {
      "code": "443",
      "label": "Chickens",
      "native": {
        "key": "Chickens:443",
        "population": "Replacements, excluding laying hens"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Replacements, excluding laying hens",
      "canonicalId": "chicken",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    },
    {
      "code": "431",
      "label": "Chickens",
      "native": {
        "key": "Chickens:431",
        "population": "Broilers up to 16 weeks"
      },
      "sourceId": "us.fda.animal-drugs",
      "population": "Broilers up to 16 weeks",
      "canonicalId": "chicken",
      "mappingStatus": "mapped",
      "mappingVersion": 1
    }
  ],
  "informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
  "ingredientScope": "application-level; no product-specific composition inferred",
  "nativePublishDate": "2026-02-13",
  "sourceDisposition": "reviewed-veterinary-application-product",
  "useDomainEvidence": {
    "basis": "publisher-dataset-scope",
    "field": "sourceId",
    "value": "us.fda.animal-drugs",
    "version": 1,
    "sourceId": "us.fda.animal-drugs"
  },
  "withdrawalPeriods": [],
  "patientEligibility": "not-assessed",
  "nativeApplicationId": 372,
  "targetSpeciesStatus": "reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "activeIngredientsText": "Amprolium\nBacitracin methylenedisalicylate\nEthopabate\n",
  "nativeApplicationType": "N",
  "applicationIngredients": [
    {
      "activeIngredientName": "Amprolium",
      "activeIngredientTolerance": "Tolerances are established as follows for residues of amprolium (1-(4-amino-2-n- propyl-5-pyrimidinylmethyl)-2-picolinium chloride hydrochloride): a. In chickens and turkeys (edible tissues): (1) 1 part per million in uncooked liver and kidney. (2) 0.5 part per million in uncooked muscle tissue. b. In chicken and turkey eggs: (1) 8 parts per million in egg yolks. (2) 4 parts per million in whole eggs. c. In calves (edible tissues): (1) 2.0 parts per million in uncooked fat. (2) 0.5 part per million in uncooked muscle tissue, liver, and kidney. d. In pheasants (edible tissues): (1) 1 part per million in uncooked liver. (2) 0.5 part per million in uncooked muscle. "
    },
    {
      "activeIngredientName": "Ethopabate",
      "activeIngredientTolerance": "Tolerance for residues of ethopabate converted to metaphenetidine are established in the edible tissues of chickens as follows:\r\n     a.  1.5 parts per million in uncooked liver and kidney\r\n     b.  0.5 part per million in uncooked muscle"
    },
    {
      "activeIngredientName": "Bacitracin methylenedisalicylate",
      "activeIngredientTolerance": "The tolerance for residues of bacitracin from zinc bacitracin or bacitracin methylene disalicylate in uncooked edible tissues of cattle, swine, chickens, turkeys, pheasants, and quail, and in milk and eggs is 0.5 part per million"
    }
  ],
  "nativeApplicationNumber": 36304,
  "nativeProprietaryNameId": 461,
  "restrictionObservations": [
    {
      "indicationText": "Where immunity to coccidiosis is not desired; to aid in prevention of coccidiosis where severe exposure to coccidiosis from <i>Eimeria acervulina</i>, <i>E. maxima</i>, and <i>E. brunetti</i> is likely to occur. For increased rate of weight gain in broiler chickens raised in floor pens.",
      "limitationText": "Not for chickens over 16 weeks of age. Do not feed to laying chickens. As sole source of amprolium. Not for use as a treatment for outbreaks of coccidiosis. Feed as the sole ration from the time chickens are placed on litter until past the time when coccidiosis is ordinarily a hazard. Do not use in Type B or Type C medicated feeds containing bentonite.",
      "populationText": "Chickens (broilers and replacements)"
    }
  ],
  "withdrawalPeriodsStatus": "not-reported",
  "publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
  "nativeNoticeOfHearingDate": null,
  "nativeApplicationStatusCode": "A",
  "nativeVoluntaryWithdrawalDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.animal-drugs" \
  --data-urlencode "id=us:fda:animaldrugs:372:461"